-
With over 20 years of experience in human nutrition. We help you deliver better nutrition in your foods, beverages, or supplements.
Check out our animal nutrition ingredients, designed to boost the health and vitality of all your favorite livestock. -
We provide tailored health solutions across various fields with independent R&D technology.
We offer professional teams to deliver customized solutions based on your product requirements. -
Address common doubts and curiosities, offering clear and informative solutions. We demystify common queries and provide valuable insights in every issue!
You can access comprehensive information to stay informed and ahead in your field. Explore and download our extensive library today! -
Recently, INNOBIO's LocVita® Pine-Based Vitamin D3 has officially passed the certification of the FSSAI and is permitted to enter the Indian market as a vegetarian functional nutritional ingredient.
INNOBIO Europe B.V, the European branch of INNOBIO Co., Ltd. was launched in Rotterdam, Netherlands. -
INNOBIO’s microencapsulation technology has evolved into its third generation (IMT 3.0) through iterative research of active ingredients, microencapsulating materials, equipment, and more.
With our patented biosynthesis technology platform, INNOBIO strives to provide an alternative to chemical synthesis to provide more natural and healthy ingredients to the nutrition industry.
Durlip™ High-Bioavailability Astaxanthin Sets New Standard with 20.6X Superior Absorption
Aug 25,2026
多行文本内容元素
富文本内容绑定数据后可解析HTML语言内容
INNOBIO’s liposomal technology is revolutionizing astaxanthin supplementation by overcoming the long-standing bioavailability challenges of this ingredient.
With the advent of Durlip™High-Bioavailability Astaxanthin, the nutraceutical sector is undergoing a major transformation regarding carotenoid supplements. Being a new liposomal formulation, it boasts a total bioavailability 20.6 times higher than standard astaxanthin oil. This breakthrough by INNOBIO makes the long-existing problem of poor absorption applicable.
The Bioavailability Barrier in Conventional Astaxanthin
Astaxanthin is a naturally occurring carotenoid known for its potent antioxidant properties, but it has traditionally faced a serious obstacle - low water solubility and poor bioavailability in oral consumption. Traditional astaxanthin oil formula has serious problems regarding absorption that limits the usage of this component to its full potential. Even if astaxanthin is taken orally, a considerable part of the component does not enter the bloodstream, so its functionality for different purposes - from joint pain and skin care issues to cognitive issues - remains impaired.
How Durlip™ Technology Achieves 20.6X Higher Absorption
The Durlip™ platform resolves this problem via a sophisticated liposomal encapsulation system that secures the active ingredient from gastric destruction and allows targeted delivery to absorption sites. By enclosing astaxanthin molecules in phospholipid bilayers, the technology shields them from stomach acid and enzymatic degradation. As a result, a much greater percentage of the active compound reaches the intestinal epithelium intact and is absorbed into the bloodstream.
Comparative studies confirm that astaxanthin encapsulated in Durlip™ has a higher relative bioavailability by 20.6 times compared to non-liposomal astaxanthin oil, representing a significant step forward in the efficiency of nutrient delivery. These data are consistent with broader research which shows that liposomal carotenoids have a higher activity of antioxidants and delivery efficiency than traditional formulations.
Clinical and Commercial Implications
This level of bioavailability improvement holds great importance for both formulators and consumers. Higher absorption means that lower doses can achieve the same or even greater effects. This improves cost effectiveness and the consumer experience by reducing pill burden and minimizing discomfort in the stomach that is usually caused by oil-containing supplements that require higher doses.
The Durlip™ family is positioned by INNOBIO as one part of a large portfolio of products based on technologies using liposomes when dealing with vitamins, minerals, and plant extracts in the market for the provision of solutions for the problems of absorption of functional nutrients concerning the consumers. The company follows strict quality assurance practices allowing its products to warrant the stability of liposomes throughout the entire production chain.
A New Era for Astaxanthin-Based Formulations
The Durlip™ High-Bioavailability Astaxanthin arrives at the right time, as the dietary supplement industry is moving towards science-based products. Customers along with healthcare professionals require products that can provide measurable results, therefore bioavailability is becoming a deciding factor when it comes to choosing the needed items.
Using Durlip™ platform enables the formulators to create an effective astaxanthin ingredient, which makes possible to develop different products aimed at specific health issues as well as combinations of products including a synergistic effect of several liposomal ingredients.
For inquiries or to request samples, please contact INNOBIO directly at info@innobioglobal.com.
Related Information
AstaGuard® Astaxanthin: Patented Microencapsulation Delivers 11.35x Higher Bioavailability
AstaGuard® Astaxanthin Emulsion Driving Innovation in Functional Beverage and Nutrition Markets
AstaGuard® Astaxanthin: Premium-Grade from Haematococcus Pluvialis
AstaGuard® Astaxanthin Supercritical CO₂-Extracted, GRAS-Certified
Oral Beauty with AstaGuard® Astaxanthin RTD & Beadlets
Get product quotes for free, find the right solution with our experts.
Know more about our organization and teams, join us or meet at an exhibition.
Keep connecting with us. Say it and be sorted.
All Rights Reserved © 2024 INNOBIO Corporation Limited